Skip to main contentSkip to search and navigation

UEF eREPOSITORY

    • English
    • suomi
  • English 
    • English
    • suomi
  • Login
View Item 
  •   Home
  • Artikkelit
  • Terveystieteiden tiedekunta
  • View Item
  •   Home
  • Artikkelit
  • Terveystieteiden tiedekunta
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Potent mechanism-based sirtuin-2-selective inhibition by an in situ-generated occupant of the substrate-binding site, "selectivity pocket" and NAD+-binding site

Thumbnail
Files
Article (1.433Mb)
Self archived version
published version
Date
2017
Author(s)
Mellini Paolo
 Itoh Yukihiro
Tsumoto Hiroki
 Li Ying
Suzuki Miki
Tokuda Natsuko
Kakizawa Taeko
Miura Yuri
Takeuchi Jun
Lahtela-Kakkonen Maija
 Suzuki Takayoshi
Unique identifier
10.1039/C7SC02738A
Metadata
Show full item record
More information
Research Database SoleCris

Self-archived article

Citation
Mellini Paolo.  Itoh Yukihiro. Tsumoto Hiroki.  Li Ying. Suzuki Miki. Tokuda Natsuko. Kakizawa Taeko. Miura Yuri. Takeuchi Jun. Lahtela-Kakkonen Maija.  Suzuki Takayoshi. (2017). Potent mechanism-based sirtuin-2-selective inhibition by an in situ-generated occupant of the substrate-binding site, "selectivity pocket" and NAD+-binding site.  Chemical science, (8) , 6400-6408. 10.1039/C7SC02738A.
Rights
© The Royal Society of Chemistry
Licensed under
CC BY http://creativecommons.org/licenses/by/3.0/
Abstract

Sirtuin 2 (SIRT2), a member of the NAD+-dependent histone deacetylase family, has recently received increasing attention due to its potential involvement in neurodegenerative diseases and the progression of cancer. Potent and selective SIRT2 inhibitors thus represent desirable biological probes. Based on the X-ray crystal structure of SIRT2 in complex with a previously reported weak inhibitor (6), we identified in this study the potent mechanism-based inactivator KPM-2 (36), which is selective toward SIRT2. Compound 36 engages in a nucleophilic attack toward NAD+ at the active site of SIRT2, which affords a stable 36-ADP-ribose conjugate that simultaneously occupies the substrate-binding site, the “selectivity pocket” and the NAD+-binding site. Moreover, 36 exhibits antiproliferative activity in cancer cells and remarkable neurite outgrowth activity. This strategy for the selective inhibition of SIRT2 should allow further probing of the biology of SIRT2, and promote the development of new disease treatment strategies.

URI
https://erepo.uef.fi/handle/123456789/5136
Link to the original item
http://dx.doi.org/10.1039/C7SC02738A
Publisher
Royal Society of Chemistry (RSC)
Collections
  • Terveystieteiden tiedekunta [1330]
University of Eastern Finland
OpenAccess
eRepo
erepo@uef.fi
UEF Open Science
Accessibility in eRepo
Service provided by
the University of Eastern Finland Library
Library web pages
Twitter
Facebook
Youtube
Library blog
 sitemap
Search

Browse

All of the ArchiveResource types & CollectionsBy Issue DateAuthorsTitlesSubjectsFacultyDepartmentFull organizationSeriesMain subjectThis CollectionBy Issue DateAuthorsTitlesSubjectsFacultyDepartmentFull organizationSeriesMain subject

My Account

Login
University of Eastern Finland
OpenAccess
eRepo
erepo@uef.fi
UEF Open Science
Accessibility in eRepo
Service provided by
the University of Eastern Finland Library
Library web pages
Twitter
Facebook
Youtube
Library blog
 sitemap